WORK Medical Establishes U.S. Subsidiary, Eyes Global Expansion
WOK sits 26% above its 52-week low of $0.088 on elevated volume (3.1× avg).
Summary
WORK Medical Technology Group has established Work Bio Technologies Ltd (WBT) as its wholly-owned U.S. subsidiary in Nevada. This move follows a 6-K filing on May 27th that briefly mentioned forming a new subsidiary. WBT will serve as the primary operational platform in the U.S., aiming to strengthen commercial presence and manage supply chains. This is a significant step for the China-based medical device supplier to expand into the U.S. market, where 17 of its products are already FDA registered.
At the time of this announcement, WOK was trading at $0.11 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $126.9K. The 52-week trading range was $0.09 to $9,300.00. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.